Alkermes (ALKS) Current Assets (2011 - 2026)
Alkermes' (ALKS) quarterly Current Assets came in at $1.4 billion in Q1 2026, down 8.14% year-on-year from $1.5 billion in Q1 2025, and down 29.57% on a QoQ basis from $1.9 billion in Q4 2025.
Alkermes (ALKS) Current Assets (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Current Assets data on file, last reported at $1.4 billion in Q1 2026.
- On a quarterly basis, Current Assets fell 8.14% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 8.14% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 36.3% from the prior year.
- Current Assets for Q1 2026 stood at $1.4 billion, down from $1.9 billion in the prior quarter.
- Over the last five years, Current Assets for ALKS reached as high as $1.9 billion in Q4 2025 and fell as low as $1.0 billion in Q1 2022.
- Historically, Current Assets has averaged $1.4 billion across 5 years, with a median of $1.5 billion in 2023.
- Across the five-year window, Current Assets jumped 39.0% in 2023 and fell 8.14% in 2026, its largest moves.
- Year by year, Current Assets stood at $1.1 billion in 2022, then surged by 31.43% to $1.5 billion in 2023, then decreased by 4.72% to $1.4 billion in 2024, then jumped by 36.3% to $1.9 billion in 2025, then fell by 29.57% to $1.4 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $1.4 billion in Q1 2026, $1.9 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 1.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.74 Bn |
| Jun 30, 2025 | 1.64 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | 1.42 Bn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.54 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.01 Bn |
| Dec 31, 2021 | 1.06 Bn |
| Sep 30, 2021 | 1.05 Bn |
| Jun 30, 2021 | 1.04 Bn |